Reuters logo
12 天前
BRIEF-ARCA Biopharma to share top-line results in Q1 next year for GENETIC-AF trial​
2017年8月9日 / 晚上9点03分 / 12 天前

BRIEF-ARCA Biopharma to share top-line results in Q1 next year for GENETIC-AF trial​

Aug 9 (Reuters) - ARCA Biopharma Inc:

* ARCA Biopharma announces GENETIC-AF data and safety monitoring board recommendation to complete Phase 2B GENETIC-AF clinical trial based on efficacy and safety data in phase 2b interim analysis

* ARCA Biopharma Inc - ‍Gencaro development program has been granted fast track designation by U.S. FDA​

* ARCA Biopharma Inc - ‍look forward to sharing top-line trial results late in Q1 of next year for GENETIC-AF trial​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below